COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Zimbabwean Art Exhibit and Sale to Benefit HIV/AIDS Research

 

April 25, 2008  |  

The University of California, San Diego AIDS Research Institute (ARI) and the ZATA (Zimbabwe AIDS Treatment Assistance) Project will co-sponsor a Zimbabwean art exhibit and sale to raise funds for AIDS treatment in Zimbabwe, Africa and to benefit HIV/AIDS research at the UC San Diego School of Medicine.

The event will be held on Saturday, May 10 from 4 p.m. to 7 p.m. at the Mission Hills United Church of Christ at 4070 Jackdaw Street, San Diego.  Admission is $20.

The event will include sale of Zimbabwean paintings, masks and story quilts. The ARI at UC San Diego is actively involved in research studies in Zimbabwe as well as nine other countries. Faculty physicians and researchers who have collaborated on HIV/AIDS clinical trials with the University of Zimbabwe faculty will be present to meet with participants and answer questions.

To register or for more information, call 858-534-5545 or e-mail cfar@ucsd.edu

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu


Related Specialties

AIDS/HIV



Media Contact

Share This Article


Related News

1/12/2021
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive ...
1/10/2021
University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Sciences researchers report that starting tobacco products, including e-cigarettes, before the age of 18 ...
1/7/2021
Chemicals used for vaping break down zipper-like junctions between cells in the gut, leading to chronic inflammation and potential for other health concerns.
1/5/2021
UC San Diego Health’s lung, heart, kidney and liver transplant programs rank at the top nationally in the latest biannual Scientific Registry of Transplant Recipients (SRTR) report. Innovative treatme ...



Follow Us